News | August 13, 2023
Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The company reported lifetime high EBIDTA of Rs. 250 crores
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
